معرفی
Qing Deng is a Professor in the Department of Biological Sciences at Purdue University, affiliated with the College of Science. His research focuses on neutrophil biology, immune engineering, and epigenetic mechanisms in cancer and inflammatory diseases. The Deng Lab uses zebrafish models to study neutrophil migration and activation, translating findings into human health applications such as therapies for chronic inflammation and cancer. Collaborations with the Bao lab involve developing stem-cell-derived neutrophil products for adoptive transfer therapy targeting solid tumors.
Education and career details are not explicitly provided in texts, but his extensive publication record indicates deep expertise in molecular biology and oncology. His lab emphasizes translational research, bridging basic science with clinical applications. The lab’s work spans protein arginine methyltransferase 5 (PRMT5) as a therapeutic target, radiation-induced neuroendocrine differentiation, and lipid metabolism regulation.
Research interests prominently feature PRMT5’s role in cancer progression, epigenetic regulation, and immune responses. Recent articles highlight advancements in radiosensitization strategies, drug discovery for neuroendocrine differentiation, and SARS-CoV-2 genomic analysis. These studies underscore a focus on mechanistic insights and therapeutic development.
No scientific awards are explicitly mentioned, but his active grant-funded research and collaborations suggest significant contributions to the field. The lab actively engages in training researchers and mentoring graduate students/postdocs, though specific names are not listed here. The Deng Lab maintains an active presence with a dedicated website and collaborates across disciplines to advance immune engineering and cancer therapy.
